MedMira Inc.
MIR.V
TSX
| 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -21.66% | -30.78% | -55.86% | -47.93% | 78.41% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -21.66% | -30.78% | -55.86% | -47.93% | 78.41% |
| Cost of Revenue | -13.82% | -12.17% | -22.38% | -4.50% | 55.27% |
| Gross Profit | 11.34% | 1.69% | -15.19% | -33.30% | -49.15% |
| SG&A Expenses | -34.77% | 13.92% | 49.69% | 24.63% | 130.96% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -18.52% | 10.01% | 67.70% | 55.61% | 87.98% |
| Operating Income | 18.28% | -15.53% | -103.62% | -76.02% | -88.74% |
| Income Before Tax | 11.75% | -20.35% | -92.96% | -65.77% | -18.90% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 11.75% | -20.35% | -92.96% | -65.77% | -18.90% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 11.75% | -20.35% | -92.96% | -65.77% | -18.90% |
| EBIT | 18.28% | -15.53% | -103.62% | -76.02% | -88.74% |
| EBITDA | 18.51% | -13.20% | -112.17% | -79.60% | -89.50% |
| EPS Basic | 8.33% | -25.00% | -100.00% | -75.00% | -20.00% |
| Normalized Basic EPS | 12.50% | -20.00% | -100.00% | -60.00% | -33.33% |
| EPS Diluted | 26.67% | -25.00% | -100.00% | -87.50% | 0.00% |
| Normalized Diluted EPS | 12.50% | -20.00% | -100.00% | -60.00% | -33.33% |
| Average Basic Shares Outstanding | 1.06% | 0.00% | 0.52% | 0.61% | -0.44% |
| Average Diluted Shares Outstanding | 1.06% | 0.00% | 0.52% | 0.61% | -0.44% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |